> > About us

About us

Based in St. Jean (Toulouse), France, Tesalys develops state-of-the-art biohazardous waste treatment solutions. Toulouse, world showcase of European industrial expertise, provides Tesalys with all the elements needed to develop its STERIPLUS™ technology internationally.

With the STERIPLUS™ shredder-sterilizer, Tesalys has quickly become a leader in on-site biohazardous waste treatment systems.

Today, Tesalys is present in more than 90 countries on five continents.

Management team :

jmrodriguez
Jean-Michel Rodriguez
(Chief Executive Officer – Partner, Administration and Finances)
mlozano
Miquel Lozano
(President – Partner, Sales and Marketing)
phengl
Patrick Hengl
(Founding partner, R&D, Technology and Quality)
ehengl
Emmanuel Hengl
(Founding Partner, R&D, Technology and Quality)

Operations team :

Stéphane Cauneille (Manufacture, Procurement)
Nicolas Leduc (Technical Support, Customer Service)
Laurent Bacque & Suzana Bosnjakovic (Global Sales Support)

 

Institutional partners :

TESALYS has been supported for the period 2014-2017 by Occitanie Pyrénées-Méditerranée Region as well as the European regional development fund (ERDF).
This financial support has contributed to R&D and IP activities, recruitment of technical and sales staff and international marketing & communication actions.
Tesalys has been supported in 2017 by the PassExport program (Region Occitanie) to promote international development actions.  

Associate Partners :

loromed venture

Other Partners :

Links

ISWA
BioMedical Alliance
ASPEC
MedicalExpo
Environmental eXpert
Reseau Dirigeants

History

madeinfrance1992
Patrick Hengl and Miquel Lozano met for the first time
Exchanges regarding biohazardous waste treatment solutions

2012
Tesalys was set up
STERIPLUS™ 20 was developed

2013
STERIPLUS™ 40 was developed
Tesalys won the Midinvest 2013 award
First sales

2014
Tesalys relocated to new premises in St. Jean (Toulouse)
Round of financing – Equity investment by Entrepreneur Venture

2015
Jury’s prize at the Inn’Ovations 2015 awards
Approval in France by the Ministry of Health and the Ministry of Ecology and Sustainable Development (NF X 30-503)
Sales in around twenty countries

2016
Marco Polo prize
EY’s prize for entrepreneur of the year
STERIPLUSTM 80 was developed
TESALYS continues its development through an external growth operation with the acquisition of Sterishred

BUSINESS SECTORS

Laboratories / Research

Voir

Hospitals / Clinics

Voir

Medical Centers

Voir

Hemodialysis centers

Voir

Other Applications

Voir